- Home
- CMMB vs TOMZ Comparison
CMMB vs TOMZ Comparison
Compare CMMB & TOMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- TOMZ
- Stock Information
- Founded
- CMMB 2004
- TOMZ 1979
- Country
- CMMB Israel
- TOMZ United States
- Employees
- CMMB N/A
- TOMZ N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- TOMZ Diversified Commercial Services
- Sector
- CMMB Health Care
- TOMZ Finance
- Exchange
- CMMB Nasdaq
- TOMZ Nasdaq
- Market Cap
- CMMB 23.0M
- TOMZ 22.6M
- IPO Year
- CMMB N/A
- TOMZ N/A
- Fundamental
- Price
- CMMB $1.19
- TOMZ $1.04
- Analyst Decision
- CMMB Strong Buy
- TOMZ Strong Buy
- Analyst Count
- CMMB 2
- TOMZ 1
- Target Price
- CMMB $8.50
- TOMZ $3.50
- AVG Volume (30 Days)
- CMMB 211.9K
- TOMZ 35.3K
- Earning Date
- CMMB 08-20-2025
- TOMZ 07-31-2025
- Dividend Yield
- CMMB N/A
- TOMZ N/A
- EPS Growth
- CMMB N/A
- TOMZ N/A
- EPS
- CMMB N/A
- TOMZ N/A
- Revenue
- CMMB N/A
- TOMZ $8,201,313.00
- Revenue This Year
- CMMB N/A
- TOMZ $3.66
- Revenue Next Year
- CMMB N/A
- TOMZ $139.63
- P/E Ratio
- CMMB N/A
- TOMZ N/A
- Revenue Growth
- CMMB N/A
- TOMZ 19.09
- 52 Week Low
- CMMB $0.87
- TOMZ $0.60
- 52 Week High
- CMMB $2.55
- TOMZ $1.50
- Technical
- Relative Strength Index (RSI)
- CMMB 40.31
- TOMZ 54.54
- Support Level
- CMMB $1.17
- TOMZ $1.00
- Resistance Level
- CMMB $1.24
- TOMZ $1.12
- Average True Range (ATR)
- CMMB 0.07
- TOMZ 0.06
- MACD
- CMMB -0.01
- TOMZ -0.01
- Stochastic Oscillator
- CMMB 34.67
- TOMZ 21.05
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.
About TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.